JPRN-jRCT2031230429招募中1 期
ONO-7475-04:A Phase1 study to examine tolerability and safety of ONO-7475 in combination with ONO-4538 and gemcitabine plus nab-paclitaxel (GnP), the standard of care, and safety of ONO-7475 in combination with GnP in patients with metastatic pancreatic cancer as first-line treatment
Hirashima Yoshinori0 个研究点目标入组 87 人开始时间: 2023年11月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 87
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Patient with metastatic pancreatic cancer
- •2.Patients have an ECOG performance status of 0 to 1
- •3.Patients with a life expectancy of at least 6 months
排除标准
- •1.Patients are unable to swallow oral medications
- •2.Patients with severe complication
研究者
相似试验
已完成
1 期
A Phase I Trial to Investigate the Tolerability, Safety, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Japanese Subjects With Metastatic or Locally Advanced Solid Tumors, With Expansion Part in Asian Subjects With Gastric CancerJPRN-jRCT2080222945Merck Biopharma Co., Ltd.57
进行中（未招募）
1 期
A Phase 1 Study to evaluate tolerability, safety and efficacy of AB122 and AB154 in Combination with Chemotherapy for Patients With Non-Small Cell Lung CancerJPRN-jRCT2051230009asermoaddeli Ali12
已完成
不适用
A pilot study to assess the tolerability and the effectiveness of combination treatment of olanzapine and escitalpram for bipolar depression in Japamajor depressive episode of bipolar disorderJPRN-UMIN000014204Department of Psychiatry, Hokkaido University Hospital60
进行中（未招募）
2 期
A study on the safety and effectiveness of fedratinib with ropeginterferon alfa-2b in patients with myelofibrosisCancerMyelofibrosisISRCTN88102629niversity of Birmingham30
招募中
1 期
A Study of Erdafitinib Intravesical Delivery System in Japanese Participants with Bladder CancerJPRN-jRCT2041220101Fujikawa Ei6